Cufstik LS Junior Syrup contains Levosalbutamol 0.5mg/5ml + Ambroxol 15mg/5ml + Guaifenesin 50mg/5ml, a combination used for relieving cough, loosening mucus, and easing bronchial spasms in children. It helps improve breathing comfort and reduce respiratory distress.
Levosalbutamol works by relaxing bronchial smooth muscles, Ambroxol breaks down and clears mucus, and Guaifenesin thins secretions, providing a comprehensive multi-action relief for pediatric patients.
This syrup is commonly prescribed for children with asthma, bronchitis, and other respiratory conditions requiring effective mucus clearance and bronchodilation. Its palatable liquid formulation ensures accurate dosing and better compliance in young patients.
For PCD pharma franchise partners, Cufstik LS Junior Syrup is a high-demand pediatric respiratory product, available at the best price for PCD pharma franchise. Its clinical effectiveness, strong prescriber trust, and wide acceptance make it a valuable addition to any pediatric pulmonary care or cough management product portfolio.